Ypsomed Holding AG operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ypsomed Holding AG with three other
medical equipment manufacturers in Europe:
Orthofix International NV
of the Netherlands
sales of 380.84 million Euro [US$471.33 million]
of which 43%
Consort Medical Plc
of the United Kingdom
(£294.00 million [US$417.61 million]
of which 59%
was Aesica), and
based in Denmark
(2.36 billion Danish Kroner [US$391.26 million]
of which 39%
During the year ended March of 2017, sales at
Ypsomed Holding AG were 389.56 million Swiss Francs (US$402.02 million).
increase of 15.6%
versus 2016, when the company's sales were 336.92 million Swiss Francs.
This was the fourth straight year of sales growth at Ypsomed Holding AG.
Sales of Delivery Devices saw an increase
that was more than double the company's growth rate: sales were up
45.6% in 2017, from
168.89 million Swiss Francs to 245.86 million Swiss Francs.
Not all segments of Ypsomed Holding AG experienced an increase in sales in 2017:
sales of Diabetes Direct Business fell 15.7% to 127.93 million Swiss Francs.
Ypsomed Holding AG also experienced decreases in sales in
Other Products (down 2.8% to 15.77 million Swiss Francs)